ANTIBODY TO AND ASSAY FOR PEPTIDE LINKED-PYRIDINOLINE AS INDICATOR OF BONE RESORPTION LEVEL
    3.
    发明公开
    ANTIBODY TO AND ASSAY FOR PEPTIDE LINKED-PYRIDINOLINE AS INDICATOR OF BONE RESORPTION LEVEL 失效
    肽抗体和化验联吡啶酚作为指标骨吸收的水平

    公开(公告)号:EP0956504A2

    公开(公告)日:1999-11-17

    申请号:EP98932871.0

    申请日:1998-06-26

    申请人: SEREX, INC.

    IPC分类号: C07K16 G01N33

    摘要: An monoclonal antibody, Serex A93, recognizes peptide linked pyridinoline in Type I bone collagen fragments and can be used to quantitate bone resorption. The hybridoma producing this antibody has been deposited with the American Type Culture Collection, Rockville, MD under accession number HB-12254. The epitope reactive with the antibody is stable to acid hydrolysis and therefore is not a linear peptide. The antibody recognizes pyridinoline in bound or conjugated form, but not in the free form found in urine. The antibody is useful in immunoassays for determining bone resorption, utilizing body fluids such as urine, saliva, blood, or sweat.

    METHODS TO IMPROVE IMMUNOGENICITY OF ANTIGENS AND SPECIFICITY OF ANTIBODIES
    4.
    发明公开
    METHODS TO IMPROVE IMMUNOGENICITY OF ANTIGENS AND SPECIFICITY OF ANTIBODIES 审中-公开
    方法提高抗原抗体的免疫原性和特异性

    公开(公告)号:EP1015028A2

    公开(公告)日:2000-07-05

    申请号:EP98948385.4

    申请日:1998-09-18

    申请人: SEREX, INC.

    IPC分类号: A61K39/385 A61K39/00

    摘要: A method of improving specific immune responses to small immunogens, haptens, has been developed by changing the linkage between the hapten and carrier being used for immunization. High affinity antibodies to the hapten cotinine have been produced using this method. Antibodies to a glycated protein have also been developed, utilizing an immunogen which is composed of a glycated peptide mimic of the glycated peptide sequence which is the target epitope, wherein the peptide mimic is constructed to conformationally mimic the conformation of the peptide in the native protein, the peptide mimic contains no charged groups or other immunodominant group, and the peptide mimic is connected to a spacer sequence equivalent to a peptide spacer of between one and thirty amino acids in length, which serves to position the peptide epitope in a conformation that approximates its conformation in the native protein. In a further embodiment the peptide mimic and spacer are linked to a carrier molecule. This method has been used to produce an antibody to the glycated protein HbA1c.

    RECEPTOR:RELEASE LIGAND (RELAND) COMPLEXES AND ASSAYS AND KITS BASED THEREON
    5.
    发明公开
    RECEPTOR:RELEASE LIGAND (RELAND) COMPLEXES AND ASSAYS AND KITS BASED THEREON 失效
    受体FREIGABELIGAND(雷兰)的获得方法络合物测试和方法

    公开(公告)号:EP0840895A1

    公开(公告)日:1998-05-13

    申请号:EP96923333.0

    申请日:1996-06-19

    申请人: SEREX INC.

    IPC分类号: G01N33

    摘要: Receptor:release ligand complexes and kits based thereon are used in a method for assaying for the presence of analyte in a sample, by detecting a released component of the complex -- receptor or ligand. The complexes are stable in the absence of analyte, but unstable when contacted with the analyte, leading to release of the ligand. The term 'release ligand' or 'reland' is applied to such a ligand. Either the released ligand or released receptor is detected by means of a detection system carried by either. The receptor:ligand complex may be formed in situ or may be pre-formed.

    DIFFERENTIAL BINDING AFFINITIES AND DISSOCIATION ASSAYS BASED THEREON
    6.
    发明公开
    DIFFERENTIAL BINDING AFFINITIES AND DISSOCIATION ASSAYS BASED THEREON 失效
    差异结合亲和力和基于事实的DISSOZIATIONSTESTVERFAHREN。

    公开(公告)号:EP0600936A1

    公开(公告)日:1994-06-15

    申请号:EP92916797.0

    申请日:1992-07-29

    申请人: SEREX INC.

    IPC分类号: G01N33

    摘要: Un procédé de détermination de la présence d'un analyte dans un échantillon, basé sur l'affinité de liaison différentielle, consiste à détecter la dissociation d'un complexe récepteur-ligand en présence d'un analyte. Le récepteur lie l'analyte avec une affinité élevée et se lie au ligand avec une faible affinité. Le complexe récepteur-ligand peut être formé in situ ou peut être formé préalablement. En présence de l'analyte libre, le récepteur se libère du complexe récepteur-ligand et se lie à l'analyte libre. La libération du récepteur du complexe récepteur-ligand peut être détectée. Du kit permettant de mettre en oeuvre des analyses de détection basées sur la libération afin de détecter la présence de l'analyte est aussi décrit.